Evenity 105mg-EU (Romosozumab PFS) 105mg x 1.17ml

Evenity 105mg-EU (romosozumab) is a prescription injection for postmenopausal osteoporosis. This prefilled syringe helps strengthen bones and reduce fracture risk. Store between 2–8°C to maintain potency. Always follow healthcare provider guidance when using.

Strength

105mg x 1.17ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

UCB Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Romosozumab is used to treat osteoporosis in postmenopausal women at high risk of fracture. It works by increasing bone formation and reducing bone breakdown. This medication is typically prescribed when other osteoporosis treatments have not been effective. It is not intended for long-term use.

Side Effects

Users may experience mild injection-site reactions like redness or swelling. Some report temporary muscle or joint pain after administration. Headaches are occasionally reported but usually resolve quickly. These effects vary by individual and are not experienced by everyone.

Precautions & Warnings

Keep the prefilled syringe refrigerated between 2–8°C and protect it from light. Do not freeze or shake the syringe. Use within the recommended timeframe after removal from refrigeration. Dispose of used syringes in a sharps container as directed by local regulations.

Avoid Interactions

Avoid combining romosozumab with other osteoporosis medications unless directed by a healthcare professional. Alcohol may reduce bone density benefits over time. No major food interactions are known, but always inform your provider about all medications and supplements you take.

Frequently Asked Questions

Store the syringes in the refrigerator between 2–8°C and use them within the labeled timeframe after removal.

Contact your healthcare provider for guidance if a dose is missed; do not take extra doses to compensate.

Yes, but keep the syringes in a temperature-controlled container between 2–8°C during transport.

Romosozumab is typically prescribed for a limited duration; discuss your treatment timeline with your healthcare provider.

Mild injection-site reactions and occasional headaches are the most commonly reported effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.